As filed with the Securities and Exchange Commission on August 27, 2024
Registration No. 333-281690
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
to
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Tectonic Therapeutic, Inc.
(Exact name of registrant as specified in its charter)
| | |
Delaware | | 83-0710585 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| |
490 Arsenal Way Suite 210 Watertown, MA | | 02472 |
(Address of Principal Executive Offices) | | (Zip Code) |
2019 Equity Incentive Plan
2024 Equity Incentive Plan
2024 Employee Stock Purchase Plan
(Full titles of the plans)
Daniel Lochner
Chief Financial Officer
490 Arsenal Way
Suite 210
Watertown, MA 02472
(339) 666-3320
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Marc A. Recht
Courtney T. Thorne
Katherine Denby
Cooley LLP
500 Boylston Street, 14th Floor
Boston, MA 02116
(617) 937-2300
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | |
Large accelerated filer | | ☐ | | Accelerated Filer | | ☐ |
| | | |
Non-accelerated filer | | ☒ | | Smaller reporting company | | ☒ |
| | | |
| | | | Emerging growth company | | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐